» Articles » PMID: 37752433

Validation of STREM-1 and IL-6 Based Algorithms for Outcome Prediction of COVID-19

Abstract

Background: A prospective observational cohort study of COVID-19 patients in a single Emergency Department (ED) showed that sTREM-1- and IL-6-based algorithms were highly predictive of adverse outcome (Van Singer et al. J Allergy Clin Immunol 2021). We aim to validate the performance of these algorithms at ED presentation.

Methods: This multicentric prospective observational study of PCR-confirmed COVID-19 adult patients was conducted in the ED of three Swiss hospitals. Data of the three centers were retrospectively completed and merged. We determined the predictive accuracy of the sTREM-1-based algorithm for 30-day intubation/mortality. We also determined the performance of the IL-6-based algorithm using data from one center for 30-day oxygen requirement.

Results: 373 patients were included in the validation cohort, 139 (37%) in Lausanne, 93 (25%) in St.Gallen and 141 (38%) in EOC. Overall, 18% (93/373) patients died or were intubated by day 30. In Lausanne, 66% (92/139) patients required oxygen by day 30. The predictive accuracy of sTREM-1 and IL-6 were similar compared to the derivation cohort. The sTREM-1-based algorithm confirmed excellent sensitivity (90% versus 100% in the derivation cohort) and negative predictive value (94% versus 100%) for 30-day intubation/mortality. The IL-6-based algorithm performance was acceptable with a sensitivity of 85% versus 98% in the derivation cohort and a negative predictive value of 60% versus 92%.

Conclusion: The sTREM-1 algorithm demonstrated good reproducibility. A prospective randomized controlled trial, comparing outcomes with and without the algorithm, is necessary to assess its safety and impact on hospital and ICU admission rates. The IL-6 algorithm showed acceptable validity in a single center and need additional validation before widespread implementation.

References
1.
Tanne J . Covid-19: Pfizer-BioNTech vaccine is rolled out in US. BMJ. 2020; 371:m4836. DOI: 10.1136/bmj.m4836. View

2.
Emanuel E, Persad G, Upshur R, Thome B, Parker M, Glickman A . Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020; 382(21):2049-2055. DOI: 10.1056/NEJMsb2005114. View

3.
Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T . Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020; 57(6):389-399. PMC: 7284147. DOI: 10.1080/10408363.2020.1770685. View

4.
Chandna A, Mahajan R, Gautam P, Mwandigha L, Gunasekaran K, Bhusan D . Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings. Clin Infect Dis. 2022; 75(1):e368-e379. PMC: 9129107. DOI: 10.1093/cid/ciac224. View

5.
Van Singer M, Brahier T, Ngai M, Wright J, Weckman A, Erice C . COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department. J Allergy Clin Immunol. 2020; 147(1):99-106.e4. PMC: 7546666. DOI: 10.1016/j.jaci.2020.10.001. View